Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Smoking Reduction on Endothelial Glucocalyx and Arterial Wall Properites During Medically-aided Smoking Cessation Program.

NCT02307045 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT02307045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02307045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Smoking Reduction on Endothelial Glucocalyx and Arterial Wall Properites During Medically-aided Smoking Cessation Program.
Lead sponsor
University of Athens
Phase
Phase 4
Overall status
Unknown status
Start date
December 3, 2014
Completion date
December 31, 2020
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation